DR ING HC F PORSCHE AG (P911.DE) Fundamental Analysis & Valuation

FRA:P911 • DE000PAG9113

Current stock price

36.46 EUR
-0.72 (-1.94%)
Last:

This P911.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. P911.DE Profitability Analysis

1.1 Basic Checks

  • P911 had positive earnings in the past year.
  • P911 had a positive operating cash flow in the past year.
  • P911 had positive earnings in each of the past 5 years.
  • Each year in the past 5 years P911 had a positive operating cash flow.
P911.DE Yearly Net Income VS EBIT VS OCF VS FCFP911.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

  • With a decent Return On Assets value of 3.88%, P911 is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • P911 has a Return On Equity of 9.19%. This is in the better half of the industry: P911 outperforms 80.00% of its industry peers.
  • P911's Return On Invested Capital of 6.83% is fine compared to the rest of the industry. P911 outperforms 80.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for P911 is significantly above the industry average of 6.04%.
  • The 3 year average ROIC (13.25%) for P911 is well above the current ROIC(6.83%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.88%
ROE 9.19%
ROIC 6.83%
ROA(3y)9.11%
ROA(5y)8.43%
ROE(3y)22.84%
ROE(5y)20.35%
ROIC(3y)13.25%
ROIC(5y)11.73%
P911.DE Yearly ROA, ROE, ROICP911.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • The Profit Margin of P911 (3.69%) is better than 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of P911 has declined.
  • With a decent Operating Margin value of 6.64%, P911 is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of P911 has declined.
  • The Gross Margin of P911 (18.85%) is comparable to the rest of the industry.
  • P911's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.64%
PM (TTM) 3.69%
GM 18.85%
OM growth 3Y-3.68%
OM growth 5Y-1.89%
PM growth 3Y-9.69%
PM growth 5Y-1.78%
GM growth 3Y-0.89%
GM growth 5Y0.39%
P911.DE Yearly Profit, Operating, Gross MarginsP911.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. P911.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so P911 is creating value.
  • P911 has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for P911 remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for P911 is higher compared to a year ago.
P911.DE Yearly Shares OutstandingP911.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
P911.DE Yearly Total Debt VS Total AssetsP911.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • The Debt to FCF ratio of P911 is 5.28, which is a neutral value as it means it would take P911, 5.28 years of fcf income to pay off all of its debts.
  • P911 has a better Debt to FCF ratio (5.28) than 80.00% of its industry peers.
  • A Debt/Equity ratio of 0.29 indicates that P911 is not too dependend on debt financing.
  • P911 has a better Debt to Equity ratio (0.29) than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.28
Altman-Z N/A
ROIC/WACC1.09
WACC6.26%
P911.DE Yearly LT Debt VS Equity VS FCFP911.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • P911 has a Current Ratio of 1.35. This is a normal value and indicates that P911 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of P911 (1.35) is better than 73.33% of its industry peers.
  • A Quick Ratio of 0.96 indicates that P911 may have some problems paying its short term obligations.
  • P911 has a Quick ratio of 0.96. This is comparable to the rest of the industry: P911 outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.96
P911.DE Yearly Current Assets VS Current LiabilitesP911.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. P911.DE Growth Analysis

3.1 Past

  • The earnings per share for P911 have decreased strongly by -30.27% in the last year.
  • The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
  • P911 shows a decrease in Revenue. In the last year, the revenue decreased by -1.10%.
  • The Revenue has been growing slightly by 7.05% on average over the past years.
EPS 1Y (TTM)-30.27%
EPS 3Y-3.83%
EPS 5Y5.12%
EPS Q2Q%-198.51%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y6.55%
Revenue growth 5Y7.05%
Sales Q2Q%-4.39%

3.2 Future

  • P911 is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.28% yearly.
  • Based on estimates for the next years, P911 will show a small growth in Revenue. The Revenue will grow by 3.18% on average per year.
EPS Next Y-83.94%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
EPS Next 5Y-2.28%
Revenue Next Year-6.14%
Revenue Next 2Y-2.84%
Revenue Next 3Y-1.13%
Revenue Next 5Y3.18%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
P911.DE Yearly Revenue VS EstimatesP911.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B 40B 50B
P911.DE Yearly EPS VS EstimatesP911.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. P911.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.25, the valuation of P911 can be described as reasonable.
  • P911's Price/Earnings ratio is a bit cheaper when compared to the industry. P911 is cheaper than 73.33% of the companies in the same industry.
  • P911's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.79.
  • P911 is valuated correctly with a Price/Forward Earnings ratio of 15.51.
  • P911's Price/Forward Earnings ratio is in line with the industry average.
  • P911 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.25
Fwd PE 15.51
P911.DE Price Earnings VS Forward Price EarningsP911.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • P911's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. P911 is cheaper than 86.67% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of P911 indicates a somewhat cheap valuation: P911 is cheaper than 80.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.67
EV/EBITDA 1
P911.DE Per share dataP911.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The decent profitability rating of P911 may justify a higher PE ratio.
  • A cheap valuation may be justified as P911's earnings are expected to decrease with -10.58% in the coming years.
PEG (NY)N/A
PEG (5Y)1.81
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. P911.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.58%, P911 is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 3.62, P911 pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.91, P911 pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.58%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
P911.DE Yearly Dividends per shareP911.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • P911 pays out 100.96% of its income as dividend. This is not a sustainable payout ratio.
DP100.96%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
P911.DE Yearly Income VS Free CF VS DividendP911.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
P911.DE Dividend Payout.P911.DE Dividend Payout, showing the Payout Ratio.P911.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

P911.DE Fundamentals: All Metrics, Ratios and Statistics

DR ING HC F PORSCHE AG

FRA:P911 (3/19/2026, 5:36:15 PM)

36.46

-0.72 (-1.94%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)10-10
Earnings (Next)03-11
Inst Owners11.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.61B
Revenue(TTM)56.35B
Net Income(TTM)2.08B
Analysts52.73
Price Target45.8 (25.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.58%
Yearly Dividend2.31
Dividend Growth(5Y)N/A
DP100.96%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-98.95%
Min EPS beat(2)-263.81%
Max EPS beat(2)65.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.24%
Min Revenue beat(2)-9.69%
Max Revenue beat(2)-0.79%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.36%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 9.25
Fwd PE 15.51
P/S 0.29
P/FCF 7.67
P/OCF 3.43
P/B 0.73
P/tB 1.15
EV/EBITDA 1
EPS(TTM)3.94
EY10.81%
EPS(NY)2.35
Fwd EY6.45%
FCF(TTM)4.75
FCFY13.03%
OCF(TTM)10.64
OCFY29.18%
SpS123.71
BVpS49.69
TBVpS31.71
PEG (NY)N/A
PEG (5Y)1.81
Graham Number66.37
Profitability
Industry RankSector Rank
ROA 3.88%
ROE 9.19%
ROCE 9.85%
ROIC 6.83%
ROICexc 10.13%
ROICexgc 14.89%
OM 6.64%
PM (TTM) 3.69%
GM 18.85%
FCFM 3.84%
ROA(3y)9.11%
ROA(5y)8.43%
ROE(3y)22.84%
ROE(5y)20.35%
ROIC(3y)13.25%
ROIC(5y)11.73%
ROICexc(3y)18.5%
ROICexc(5y)16.21%
ROICexgc(3y)27.68%
ROICexgc(5y)23.14%
ROCE(3y)19.1%
ROCE(5y)16.92%
ROICexgc growth 3Y2.85%
ROICexgc growth 5Y3.55%
ROICexc growth 3Y-0.44%
ROICexc growth 5Y1.03%
OM growth 3Y-3.68%
OM growth 5Y-1.89%
PM growth 3Y-9.69%
PM growth 5Y-1.78%
GM growth 3Y-0.89%
GM growth 5Y0.39%
F-Score5
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.28
Debt/EBITDA 0.73
Cap/Depr 52.89%
Cap/Sales 4.76%
Interest Coverage 250
Cash Conversion 54.98%
Profit Quality 103.99%
Current Ratio 1.35
Quick Ratio 0.96
Altman-Z N/A
F-Score5
WACC6.26%
ROIC/WACC1.09
Cap/Depr(3y)107.61%
Cap/Depr(5y)100.02%
Cap/Sales(3y)9.74%
Cap/Sales(5y)9.61%
Profit Quality(3y)66.21%
Profit Quality(5y)65.11%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.27%
EPS 3Y-3.83%
EPS 5Y5.12%
EPS Q2Q%-198.51%
EPS Next Y-83.94%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
EPS Next 5Y-2.28%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y6.55%
Revenue growth 5Y7.05%
Sales Q2Q%-4.39%
Revenue Next Year-6.14%
Revenue Next 2Y-2.84%
Revenue Next 3Y-1.13%
Revenue Next 5Y3.18%
EBIT growth 1Y-21.15%
EBIT growth 3Y2.63%
EBIT growth 5Y5.02%
EBIT Next Year-8.38%
EBIT Next 3Y10.55%
EBIT Next 5Y13.3%
FCF growth 1Y431.7%
FCF growth 3Y-8.36%
FCF growth 5Y11.7%
OCF growth 1Y-30.9%
OCF growth 3Y-0.33%
OCF growth 5Y7.21%

DR ING HC F PORSCHE AG / P911.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DR ING HC F PORSCHE AG?

ChartMill assigns a fundamental rating of 5 / 10 to P911.DE.


What is the valuation status of DR ING HC F PORSCHE AG (P911.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to DR ING HC F PORSCHE AG (P911.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DR ING HC F PORSCHE AG?

DR ING HC F PORSCHE AG (P911.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for P911 stock?

The Price/Earnings (PE) ratio for DR ING HC F PORSCHE AG (P911.DE) is 9.25 and the Price/Book (PB) ratio is 0.73.


How financially healthy is DR ING HC F PORSCHE AG?

The financial health rating of DR ING HC F PORSCHE AG (P911.DE) is 4 / 10.